Citrus Extracts

Citrus Extracts is a biotechnology company based in Fort Pierce, Florida, that specializes in the research and production of Modified Citrus Pectin (MCP). The company is the primary manufacturer of PectaSol-C, a proprietary form of MCP that has been extensively studied for its ability to inhibit Galectin-3, a protein involved in cancer progression and organ fibrosis. Their manufacturing process utilizes a specific enzymatic hydrolysis method to ensure the pectin fragments are of the correct molecular weight for systemic absorption. Citrus Extracts collaborates with various academic institutions to validate the therapeutic potential of their products in areas such as oncology, cardiovascular health, and kidney function. The company's ingredients are widely used in both clinical research settings and the high-end nutraceutical market.